| Lipotoxicity and the gut-liver axis in NASH pathogenesis F Marra, G Svegliati-Baroni Journal of hepatology 68 (2), 280-295, 2018 | 718 | 2018 |
| From the metabolic syndrome to NAFLD or vice versa? E Vanni, E Bugianesi, A Kotronen, S De Minicis, H Yki-Järvinen, ... Digestive and liver Disease 42 (5), 320-330, 2010 | 655 | 2010 |
| Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: a multicenter prospective study F Piscaglia, G Svegliati‐Baroni, A Barchetti, A Pecorelli, S Marinelli, ... Hepatology 63 (3), 827-838, 2016 | 583 | 2016 |
| Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro A Galli, DW Crabb, E Ceni, R Salzano, T Mello, G Svegliati–Baroni, ... Gastroenterology 122 (7), 1924-1940, 2002 | 553 | 2002 |
| Prolonged n‐3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non‐alcoholic fatty liver disease: a pilot study M Capanni, F Calella, MR Biagini, S Genise, L Raimondi, G Bedogni, ... Alimentary pharmacology & therapeutics 23 (8), 1143-1151, 2006 | 546 | 2006 |
| Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis F Marra, A Gastaldelli, GS Baroni, G Tell, C Tiribelli Trends in molecular medicine 14 (2), 72-81, 2008 | 534 | 2008 |
| Glucagon‐like peptide‐1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high‐fat diet in nonalcoholic steatohepatitis G Svegliati‐Baroni, S Saccomanno, C Rychlicki, L Agostinelli, ... Liver International 31 (9), 1285-1297, 2011 | 459 | 2011 |
| Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial P Caraceni, O Riggio, P Angeli, C Alessandria, S Neri, FG Foschi, ... The Lancet 391 (10138), 2417-2429, 2018 | 450 | 2018 |
| Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans A Omenetti, A Porrello, Y Jung, L Yang, Y Popov, SS Choi, RP Witek, ... The Journal of clinical investigation 118 (10), 3331-3342, 2008 | 441 | 2008 |
| Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis GS Baroni, L D'Ambrosio, P Curto, A Casini, R Mancini, AM Jezequel, ... Hepatology 23 (5), 1189-1199, 1996 | 424 | 1996 |
| Fibrogenic effect of oxidative stress on rat hepatic stellate cells GS Baroni, L D’Ambrosio, G Ferretti, A Casini, A Di Sario, R Salzano, ... Hepatology 27 (3), 720-726, 1998 | 414 | 1998 |
| Insulin and insulin‐like growth factor‐1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction … G Svegliati‐Baroni, F Ridolfi, A Di Sario, A Casini, L Marucci, G Gaggiotti, ... Hepatology 29 (6), 1743-1751, 1999 | 382 | 1999 |
| Nonalcoholic fatty liver disease: basic pathogenetic mechanisms in the progression from NAFLD to NASH I Pierantonelli, G Svegliati-Baroni Transplantation 103 (1), e1-e13, 2019 | 359 | 2019 |
| Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease: A decalogue from the Italian Association for the Study of the Liver (AISF) Expert … P Loria, LE Adinolfi, S Bellentani, E Bugianesi, A Grieco, S Fargion, ... Digestive and Liver Disease 42 (4), 272-282, 2010 | 345 | 2010 |
| A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-α and n-3 polyunsaturated fatty acid treatment on … G Svegliati-Baroni, C Candelaresi, S Saccomanno, G Ferretti, T Bachetti, ... The American journal of pathology 169 (3), 846-860, 2006 | 323 | 2006 |
| Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2‐mediated mechanism A Galli, G Svegliati‐Baroni, E Ceni, S Milani, F Ridolfi, R Salzano, ... Hepatology 41 (5), 1074-1084, 2005 | 310 | 2005 |
| AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions A Lonardo, F Nascimbeni, G Targher, M Bernardi, F Bonino, E Bugianesi, ... Digestive and Liver Disease 49 (5), 471-483, 2017 | 309 | 2017 |
| Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice S De Minicis, C Rychlicki, L Agostinelli, S Saccomanno, C Candelaresi, ... Hepatology 59 (5), 1738-1749, 2014 | 284 | 2014 |
| Increased liver localization of lipopolysaccharides in human and experimental NAFLD G Carpino, M Del Ben, D Pastori, R Carnevale, F Baratta, D Overi, ... Hepatology 72 (2), 470-485, 2020 | 257 | 2020 |
| Pathophysiology of non alcoholic fatty liver disease S Petta, A Gastaldelli, E Rebelos, E Bugianesi, P Messa, L Miele, ... International journal of molecular sciences 17 (12), 2082, 2016 | 218 | 2016 |
